Bleeding control algorithm when using MHT (EN)

Discover the latest in menopausal bleeding control with this on-demand webinar. Presented by expert Natalia Pedachenko and chaired by Marco Gambacciani, this informative session delves into the intricacies of managing bleeding issues during Menopausal Hormone Therapy (MHT).

Gain valuable insights into evidence-based algorithms and best practices for effective bleeding management.

Available in multiple languages, including English, Spanish, Ukrainian, Portuguese, and Mandarin, this webinar offers essential knowledge for healthcare professionals seeking to optimize patient outcomes in MHT.

Don’t miss this opportunity to enhance your clinical expertise and patient care. Watch now and stay informed about the latest advancements in MHT bleeding control strategies.

Absolute MHT contraindications:

  • Past diagnosis or suspicion of breast cancer.
  • Diagnosed in the past or suspicion of estrogen-dependent malignant tumors (for example, endometrial cancer III, IV stage and poorly differentiated endometrial cancer).
  • Established progestagen-dependent neoplasms (for example, meningioma) or suspicion of them.
  • Vaginal bleeding of unknown origin.
  • Untreated endometrial hyperplasia.
  • Presence of VTE (deep vein thrombosis, pulmonary embolism) or VTE in the past.
  • Known thrombophilias (eg, protein C deficiency, protein S or antithrombin III).
  • Active or recent thromboembolic arterial disease (eg angina pectoris, myocardial infarction (MI).
  • Acute liver diseases, as well as the presence of liver diseases in the past, if the indicators of its function have not normalized.
  • Known hypersensitivity to the active substances or to any of the excipients
    substances of the medicinal product.
  • Porphyria.

Relative contraindications:

  • Uterine leiomyoma.
  • Endometriosis.
  • Migraine.
  • Familial hypertriglyceridemia.
  • Gallstone disease.
  • Epilepsy.
  • Increased risk of developing breast cancer.
  • Endometrial cancer I and II st.

Tatarchuk T.F., Anikusko M.F., Bulavenko O.V., Horban N.E., Doljenko M.M., Dubossarska U.A., Jylko N.Y., Zanko O.V., Isaeva H.S., Kalugina L.V., Kamiskiy V.V., Kosey N.V., Malyshevska Y.V., Medved V.I., Mitchenko O.I., Pedachenko N.Y., Regeda S.I., Efimenko O.O. Ministry of Health of Ukraine. Unified clinical protocol ”Menopausal and other disorders in perimenopausal period”, implemented in accordance with the Order of the Ministry of Health of Ukraine dated June 17, 2022, No. 1039.